Joseph P. Lucia & Associates, LLC Inovio Pharmaceuticals, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.44 - $3.98 $325 - $899	-226 Reduced 9.0%	2,284 $4,000
Q1 2022 Apr 19, 2022	BUY	$2.97 - $5.2 $7,454 - $13,052	2,510 New	2,510 $9,000
Q4 2021 Feb 04, 2022	SELL	$4.99 - $7.46 $15,394 - $23,014	-3,085 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$7.16 - $9.69 $14 - $19	-2 Reduced 0.06%	3,085 $22,000
Q2 2021 Jul 27, 2021	SELL	$6.23 - $10.03 $1,102 - $1,775	-177 Reduced 5.42%	3,087 $29,000
Q1 2021 Apr 23, 2021	BUY	$8.81 - $16.96 $8 - $16	1 Added 0.03%	3,264 $30,000
Q4 2020 Jan 29, 2021	BUY	$8.5 - $12.85 $27,735 - $41,929	3,263 New	3,263 $29,000
Q3 2020 Oct 20, 2020	SELL	$9.57 - $27.05 $29,686 - $83,909	-3,102 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$7.14 - $31.69 $6,832 - $30,327	957 Added 44.62%	3,102 $84,000
Q1 2020 Apr 22, 2020	BUY	$2.98 - $14.09 $357 - $1,690	120 Added 5.93%	2,145 $16,000
Q4 2019 Jan 23, 2020	SELL	$1.97 - $3.72 $45 - $85	-23 Reduced 1.12%	2,025 $7,000
Q2 2019 Jul 23, 2019	BUY	$2.29 - $4.1 $4,689 - $8,396	2,048 New	2,048 $6,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.